A general method has been developed for the solid phase synthesis of drug-like 7-aryl-benzo [b] [1,4]oxazin-3(4H)-one derivatives 6. The method relies on a novel, microwave irradiation promoted cyclization reaction of the BOMBA resin bound, N-substituted-α-(2-chloro-4-bromophenoxy) 
Introduction
Heterocyclic skeletons serve as ideal scaffolds on which pharmacophores can be appended to yield potent and selective drugs.
1 This is especially true for six-member ring heterocyclic compounds, which are core components of a large number of substances that possess a wide range of interesting biological activities. 2 In this respect, the utility of the benzo [b] [1,4]oxazin scaffold as a privileged structure for the generation of druglike libraries in drug-discovery programs has been amply demonstrated. The benzo [b] [1, 4] oxazin derivatives have been used as the basic framework for substances of interest in numerous therapeutic areas, such as anti-candina albicans, 3 antifungals, 4 and kinase inhibitors. 5 As a part of a research program aimed at drug discovery and high throughput organic synthesis, we needed to develop a facile and rapid solid-phase approach for the construction of drug-like small heterocyclic molecules. 6 A specific focus of this effort was on modulators of kinase inhibitors, which have been identified as allosteric modulators of a wide variety of untreated kinases, including PI3Kinaser. 7 Our interest concentrated on the construction of benzo [b] [1, 4] oxazin derivatives since substances containing this structural platform are known to serve as PI3Kinase γ inhibitors. However, solid-phase synthetic methods to readily generate various aryl substituted benzo [b] [1,4]oxazin have not been explored. As a matter of fact, most of the known benzo [b] [1, 4] oxazin derivatives have been prepared by solution-phase synthetic routes that employ the Smiles rearrangement. 8 Thus, the goals of the current study were (1) to develop a simple and efficient solid-phase synthetic methodology to produce various 7-aryl-benzo [b] [1, 4] oxazin derivatives, and (2) to discover novel hit compounds that would be active Isolated yields after purification by flash chromatography and three-step overall yield from BOMBA resin 1 (loading capacity 1.25 mmol/g).
b
Three components one pot reaction (from 2 → 4) performed with thermal and microwave conditions. Step by step reaction performed with thermal (from 2 → 3) and microwave (from 3 → 4) conditions. kinase inhibitors.
Below, the preparative route relies on a microwave irradiation promoted, Smiles rearrangement type cyclization reaction of a N-substituted-α- (2-chloro-4-bromophenoxy) 
Results and Discussion
The sequence used to prepare the α-chloroacetamide resin 2 employs the BOMBA resin 1 as the starting polymer support. Treatment of the BOMBA resin 1 with α-chloroacetyl chloride in the presence of pyridine at room temperature leads to production of the corresponding α-chloroacetamide resin 2. The progress of this reaction was monitored by measuring the growth of typical amide stretching band at 1675 cm -1 by using ATR-FTIR. Resin 2 is first swollen in DMF and, in a manner that the route employed in the solution-phase counterpart, it is then reacted with 4-chloro-2-bromophenol to give the corresponding BOMBA resin bound, N-linked α-(2-chloro-4-bromophenoxy)acetamide 3. The progress of this reaction was monitored by using ATR-FTIR, which displayed a slightly shift of the amide band from 1675 to 1672 cm 12 An exploration of a number of methods to promote this process (Table 1) led to the finding that the optimal conditions to promote the Smiles-cyclization reaction involve the use of much higher temperatures and a microwave irradiation condition. 13 The progress of the cyclization reaction was monitored by observing the shift of the amide band from 1672 cm -1 to 1688 cm -1 in the ATR-FTIR. In this reaction, we had very difficult to find out each reaction progress using ATR-FTIR. Therefore as shown Figure 1 (Table 2) . In summary, an efficient method for the solid phase parallel synthesis of drug-like 7-aryl-benzo 
Experimental Procedures
General experimental methods. The Merrifield resin (loading capacity 2.00 mmol/g, 100-200 mesh) was obtained from Bead Tech. Most of the reagents were purchased from SigmaAldrich. Solvents were purchased from J. T. Baker and were HPLC grade. Suzuki coupling reaction was carried out on the Automated Microwave synthesis system (Emrys Creator). 13 Solvent evaporation was performed on GeneVac Atlas HT-4 centrifugal evaporator. Crude products were purified by parallel chromatography using Ouad3 TM . ATR-FTIR spectra were recorded on Travel IR TM (Sence IR Technology) spectrometer.
1 H and 13 C NMR spectra were recorded on a Bruker Advance 500 spectrophotometer. LC-UV-MS analyses were performed a Waters ZQ mass spectrometer equipped with PDA (200-400 nm) detection using XterraMS column (C18, 5M, 4.6 × 100 mm) from Waters. A typical gradient was 5-95% CH3CN/H2O containing 0.1% trifluoroacetic acid. X-ray crystallography was recorded on SMART Apex II CCD area-detector X-ray Diffractometer and SHELXTL program (Bruker). HRMS data recorded on Micromass Auto Spec MS.
Preparation of BOMBA resin (1) and determination of loading capacity. We had prepare BOMBA resin 1 by known procedure form the Merrifield resin.
9 (a) Loading: To an ice cold slurry of BOMBA resin 1 (0.20 g) and N,N-Diisopropylethylamine (0.42 mL, 2.40 mmol), was added a solution of 9-fluorenylmethoxycarbonyl chloride (0.41 g, 1.60 mmol) in CH2Cl2 (10 mL). The slurry was incubated for 3 h at room temperature. Then the resin was removed by filteration and sequentially washed with H 2 O, MeOH and CH 2 Cl 2 , Following a final wash with MeOH, the resin was dried in vacuum oven. The Fmoc-amino resin was obtained as light yellow sold (0.28 g). On bead ATR-FT IR: 3025, 2922 , 1708 (amide), 1612 , 1589 , 1493 , 1450 , 1421 , 1245 , 1197 , 1159 , 1130 , 1029 , 1019 . (b) Deloading: A suspension of the Fmoc amino resin (0.28 g) and piperidine (2 mL) in CH 2 Cl 2 (8 mL) was stirred at room temperature for 2 h. Then the resin was filtered and washed with CH2Cl2 (2 × 50.0 mL). The filtrate was concentrated in vacuo giving a residue which was subjected to silica gel column chromatography (n-hexaneEtOAc, 10:1, v/v) to afford 9-methylene-9H-fluorene (45 mg, BOMBA resin loading capacity 1.25 mmol/g).
1
H NMR (500 MHz, CDCl3) δ 6.09 (s, 2H), 7.30-7.33 (td, J = 7.5 and 1.1 Hz, 2H), 7.37-7.40 (td, J = 7.5 and 1.1 Hz, 2H), 7.70-7.71 (dt, J = 7.5 and 0.9 Hz, 2H), 7.74-7.76 (dt, J = 7.5 and 0.9 Hz, 2H).
N-Substituted α-chloroacetamide on BOMBA resin (2). To a mixture of BOMBA resin 1 (1.00 g, theoretically 1.25 mmol/g) in CH 2 Cl 2 (15.0 mL) was added pyridine (0.30 mL, 3.75 mmol) and 2-chloro acetyl chloride (0.30 mL, 3.75 mmol). The mixture was stirred in room temperature. After agitating 12 h, the resin was filtered and washed with CH2Cl2, MeOH, H2O then several times with MeOH and CH2Cl2. Following final wash with MeOH, the resin dried in vacuum oven. Resin 2 was obtained as a light brown solid (1.16 g). On bead ATR-FT IR: 3024, 2921, 1675 (C=O, amide), 1611, 1509, 1493, 1451, 1421, 1377, 1286, 1264, 1197, 1160, 1129, 1028, 1018, 822, 759, 737, 698 cm -1 . N-Substituted α-(2-chloro-4-bromophenoxy) acetamide on BOMBA resin (3). To a mixture of resin 2 (1.11 g) in DMF (15.0 mL) was added cesium carbonate (2.42 g, 7.42 mmol) and 4-bromo-2-chlorophenol (1.16 g, 5.56 mmol). The mixture was stirred at 80 o C for 12 h. After which time, the resin was filtered and washed with DMF, MeOH, H2O, then several times with MeOH and CH2Cl2. Following final wash with MeOH, the resin dried in vacuum oven. Resin 3 was obtained as a dark brown solid (1.20 g). On bead ATR-FT IR: 3024, 2922 , 1672 (C=O, amide), 1610 , 1508 , 1493 , 1451 , 1421 , 1376 , 1286 , 1261 , 1196 , 1160 , 1136 , 1127 , 1029 .
7-Bromobenzo[b][1,4]oxazin on BOMBA resin (4).
To a suspension of resin 3 (0.50 g) in DMF (12.0 mL) was added cesium carbonate (1.02 g, 3.12 mmol) were placed in a Pyrex tube. The tube was sealed, positioned in the cavity and irradiation at 200 o C for 1 h. After which time the reaction mixture was cooled to room temperature. The resin was filtered and washed with DMF, MeOH, H2O, then several times with MeOH and CH2Cl2. Following final wash with MeOH, the resin dried in vacuum oven. Resin 4 was obtained as a dark brown solid (5.05 g). On bead ATR-FT IR: 3024, 2920 , 2851 , 1688 (C=O, amide), 1603 , 1589 , 1504 , 1493 , 1451 , 1421 , 1389 , 1285 , 1264 , 1195 , 1159 , 1125 , 1115 , 1075 , 1029 . General procedure for the suzuki coupling as applied to the synthesis of 7-(3-fluoro-phenyl)benzo[b][1,4]oxazin on BO-MBA resin (5a). The resin 4 (0.25 g) was placed reaction vessel with degassed DME (1,2-dimethoxy ethane, 3.00 mL), followed by addition of Pd(PPh3)4 (36.1 mg, 0.03 mmol). A solution of 3-fluorophenyl boronic acid (0.22 g, 1.56 mmol) in degassed EtOH (0.6 mL) was added to the resin, and the mixture was agitated for 5 min and then potassium fluoride (90.8 mg, 1.56 mmol) was added. The mixture was stirred for 24 h, 60 o C. The resin was filtered and washed with MeOH, H2O then several times with MeOH and CH2Cl2. Following final wash with MeOH, the resin dried in vacuum oven. The dark brown biphenyl resin 5a (0.27 g) was obtained. On bead ATR-FT IR: 3024, 2919, 1687 (C=O, amide), 1612, 1508, 1493, 1451, 1396, 1287, 1195, 1158, 1030, 819, 758, 697 cm -1 .
General procedure for the cleavage as applied to the synthesis of 7-(3-fluoro-phenyl)benzo[b][1,4]oxazin(6a).
The resin 5a (0.27 g) was treated with a mixture of TFA/H2O (95:5, v/v) for 6 h, at 60 o C. After which time, the resin was washed with CH2Cl2 several times. The organic filtrates were neutralized by saturated NaHCO3 solution. The filtrate was washed water and dried over MgSO4. The solution was concentrated under reduced pressure and the residue was purified by column chromatography on silica gel (n-hexane/EtOAc/ CH2Cl2, 4:1:1) to afford 7-(3-fluoro-phenyl)-4H-benzo [b][1,4] oxazin-3-one, 6a (15 mg, 20%, five-step overall yield from BOMBA resin, loading capacity 1.25 mmol/g) as an white solid. 115.6, 115.8, 116.0, 116.2, 121.4, 128.5, 128.5, 136.9, 144.1, 165.3 0, 116.3, 116.5, 118.5, 121.2, 124.7, 128.5, 129.6, 129.6, 130.5, 161.5 115.2, 117.3, 118.5, 121.8, 123.9, 128.7, 135.3, 138.6, 145.2, 149.5, 165.4 .6, 19.9, 22.4, 31.4, 48.9, 54.0, 59.6, 67.1, 116.0, 116.8, 123.1, 124.7, 125.4, 127.7, 129.5, 130.4, 143.8, 164.5, 170 106.5, 116.0, 117.3, 123.4, 125.0, 126.6, 130.9, 133.8, 168. 13 C NMR(125 MHz, acetone-d6) δ 55. 0, 68.0, 115.9, 117.3, 122.2, 126.6, 128.3, 135.4, 144.9, 145.2, 165.4; MS (ESI) 67.5, 114.4, 115.2, 116.3, 121.1, 124.8, 128.0, 132.7, 137.6, 144.1, 159.4, 165.7 1, 60.7, 67.5, 111.8, 115.7, 117.8, 122.5, 123.9, 124.3, 125.1, 134.8, 134.8, 143.4, 146.7, 153.3, 166.0 67.4, 110.3, 111.7, 115.3, 116.4, 119.3, 121.2, 125.0, 133.1, 137.8, 144.0, 148.9, 149.4, 166.0 4, 115.7, 117.8, 118.3, 120.3, 123.0, 123.8, 124.2, 125.2, 129.0, 129.8, 131.1, 132.5, 134.2, 143.4, 153.8, 157.7, 166.0 9, 20.7, 67.4, 115.3, 117.9, 123.8, 125.3, 127.5, 129.1, 134.0, 139.1, 141.0, 143.2, 165.3 21.0, 67.4, 115.7, 117.7, 123.8, 124.8, 128.3, 130.5, 132.3, 135.4, 138.7, 140.7, 143.4 67.5, 116.0, 117.7, 123.6, 124.7, 127.4, 127.5, 136.3, 137.6, 140.8, 143.8, 165.5 8, 64.6, 67.5, 114.0, 115.6, 118.1, 124.0, 125.3, 125.8, 128.3, 130.4, 133.8, 143.4, 154.6, 165.9 7, 64.5, 67.4, 113.9, 115.4, 118.0, 123.9, 125.2, 125.8, 128.3, 130.3, 131.1, 133.7, 143.3, 154.5, 165.6 H NMR (500 MHz, CDCl3) δ 4.67 (2H, s), 7.12-7.14 (dd, J = 8.1, 2.0 Hz, 1H), 7.15 (d, J = 1.9 Hz, 1H), 7.21-7.17 (t, J = 8.7 Hz, 1H), 7.36-7.39 (m, 1H), 7.55-7.57 (dd, J = 6.9, 2.4 Hz, 1H), 8.22(br s, 1H); 13 C NMR (125 MHz, CDCl3) δ 67. 5, 115.6, 116.4, 117.0, 117.1, 121.4, 126.5, 126.6, 129.1, 135.6, 144.2, 165.4 
7-(3-Fluoro-phenyl)-4H-benzo[b][1,4]oxazin-3-one (6a

